Advertisement

x

Mathews Journal of Pharmaceutical Science

2474-753X

Mathews Journal of Pharmaceutical Science Reviewer Guidelines

Peer Review Process

Mathews Open Access Journals follows double blind peer review process. In this we do not reveal author names, affiliations to the reviewer and vice versa. We adhere to the Committee on Publication Ethics (COPE), code of conduct, and best practice guidelines (http://publicationethics.org). We strive to ensure that the peer review is fair, unbiased and timely. Decisions to accept or reject a manuscript for publication in the journal are based on the manuscript’s importance, originality, clarity, and the study’s validity and its relevance to remit of the journal. The process also involves strictly no plagiarism or fabrication of the data and parallel submissions.

Responsibilities

Being a reviewer you are accountable to take the responsibility of maintaining confidentiality of ideas that have been presented in the papers assigned to review. Focus your evaluation on merits and demerits of the article; assess the correctness, accuracy, clarity, and innovation of the research. Never reveal the assigned paper's results or videos/images or any of the supplementary material to non-reviewers.

The reviewers are given ample time for the review and submission of comments to the editorial office. Reviewers’ evaluations play a major role in our decision as to whether to accept a manuscript for publication.

Ethical Issues

  • The reviewer should be honest, transparent. Should not be biased in the decision, and exact analysis of the research.
  • After receiving the paper for any further assistance or clarifications you need to contact only the editorial office and the confidentiality of the paper has to be maintained.
  • You must never ask anyone to review a portion of paper without editor's permission and also must never contact the author of the paper directly.
  • Final decision in accepting/ rejecting of the manuscript is solely decided by Chief-Editor of the journal.
  • The reviewer can also inform the editor regarding suspected duplicate publication, plagiarism, or any ethical concerns about the use of animals or humans in the research that has be done by author.
Recently Published Articles
Research Article

Regulatory Update on eSubmissions in Balkans

Published : 01st April 2024
Author : Marjan Dzeparoski1,2,*
Citation : Dzeparoski M. (2024). Regulatory Update on eSubmissions in Balkans. Mathews J Pharma Sci. 8(1):26.

Research Article

Investigating the Potential of Nilotinib and its Derivatives in Targeting Tau Protein Hyperphosphorylation for Alzheimer's Disease Treatment

Published : 11th December 2023
Authors : Aria Hajihassan1, Atena Zandi1, Ghazal Esmaeili1, Mostafa Norizadeh2,3,*
Citation : Hajihassan A, et al. (2023). Investigating the Potential of Nilotinib and its Derivatives in Targeting Tau Protein Hyperphosphorylation for Alzheimer's Disease Treatment. Mathews J Pharma Sci. 7(4):25.

Research Article

Quality of Life and Medication Adherence in Rheumatoid Arthritis Patients

Published : 25th November 2023
Authors : Qadeer Ahmed, Muhammad Talha, Umer Ishtiaq, Saba Khurshid, Kaif Akbar, Urwa Amir, Muhammad Rehan, Ovais Ullah Shirazi, Shahid Latif, Zunaira Akbar, Iram Batool, Ali Akhtar*, Samreen Fatima
Citation : Ahmed Q, et al. (2023). Quality of Life and Medication Adherence in Rheumatoid Arthritis Patients. Mathews J Pharma Sci. 7(4):24.

Case Report

Desensitization in a Patient with Hypersensitivity to the Iodinated Contrast Medium Iopromide: A Clinical Case Report

Published : 03rd November 2023
Authors : Dadier Antonio Arroyo1,2,*, Linda Atencio1, Jorge Pérez Velásquez3, María Camila Coronado1, Meribeth Henry4, Maria Alejandra Suarez2, Daniela Katerine Rivera2
Citation : Arroyo DA, et al. (2023). Desensitization in a Patient with Hypersensitivity to the Iodinated Contrast Medium Iopromide: A Clinical Case Report. Mathews J Pharma Sci. 7(3):23.

Editorial Article

We Continue to Battle with Diseases that are Difficult to Diagnose and Cure in the 21st Century

Published : 17th October 2023
Author : Raúl Isea*
Citation : Isea R. (2023). We Continue to Battle with Diseases that are Difficult to Diagnose and Cure in the 21st Century. Mathews J Pharma Sci. 7(3):22.

Research Article

Four-Week Safety and Acceptability Study of 15% Bromelain Topical Lotion: An Open Label, Non-Comparative, Triple-Arm Study

Published : 11th October 2023
Authors : Allen B Richon1,*, Merry Ambos Richon2
Citation : Richon AB, et al. (2023). Four-Week Safety and Acceptability Study of 15% Bromelain Topical Lotion: An Open Label, Non-Comparative, Triple-Arm Study. Mathews J Pharma Sci. 7(3):21.

Indexed
Root Indexing
WolrdCat
J Gate
Directory of Research Journals Indexing
International Scientific Indexing
Genamics JournalSeek
Scientific Indexing Services
International Committee of Medical Journal Editors
Scilit
CiteFactor
Google Scholar
Subscribe

Subscribe to our RSS feed, be in touch with our articles, news, videos, reebies.

Antispam Code Generate new code

Creative Commons License

© 2015 Mathews Open Access Journals. All Rights Reserved.

Open Access by Mathews Open Access Journals is licensed under a
Creative Commons Attribution 4.0 International License.
Based On a Work at Mathewsopenaccess.com